Cleared Traditional

K220988 - EksoNR (FDA 510(k) Clearance)

Jun 2022
Decision
66d
Days
Class 2
Risk

K220988 is an FDA 510(k) clearance for the EksoNR. This device is classified as a Powered Exoskeleton (Class II - Special Controls, product code PHL).

Submitted by Ekso Bionics, Inc. (Richmond, US). The FDA issued a Cleared decision on June 9, 2022, 66 days after receiving the submission on April 4, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 890.3480. A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes..

Submission Details

510(k) Number K220988 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2022
Decision Date June 09, 2022
Days to Decision 66 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PHL - Powered Exoskeleton
Device Class Class II - Special Controls
CFR Regulation 21 CFR 890.3480
Definition A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes.